NCT06471621 Precision Medicine in Cardiovascular Surgery Associated Acute Kidney Injury
| NCT ID | NCT06471621 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Insel Gruppe AG, University Hospital Bern |
| Condition | Acute Kidney Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-06-16 |
| Primary Completion | 2026-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-06-16 with a primary completion date of 2026-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective observational study is to define a risk profile for cardiovascular surgery associated acute kidney injury (AKI), using clinical patient characteristics, operation parameters as well as blood and urine laboratory values. The main question it aims to answer is: • Does a combination of the factors mentioned above better predict patient outcome than classical factors used to date in clinical practice? Participants of this study are adults aged 18 and above who are scheduled for elective heart or main artery surgery, and who have given written informed consent.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing elective cardiovascular surgery, such as valvular replacement surgery, with or without combined coronary artery bypass graft (CABG), or thoracic or abdominal aortic surgery. * Written informed consent obtained prior to surgery. Exclusion Criteria: * Patients with a kidney transplant or on renal replacement therapy * Severe liver failure, defined by the presence of encephalopathy, Factor V \< 50% and INR \>1.5 on preoperative blood sample (within 4 weeks).
Contact & Investigator
Uyen Huynh-Do, Prof. MD
PRINCIPAL INVESTIGATOR
University Hospital Bern (Inselspital)
Frequently Asked Questions
Who can join the NCT06471621 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Kidney Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06471621 currently recruiting?
Yes, NCT06471621 is actively recruiting participants. Contact the research team at uyen.huynh-do@insel.ch for enrollment information.
Where is the NCT06471621 trial being conducted?
This trial is being conducted at Bern, Switzerland.
Who is sponsoring the NCT06471621 clinical trial?
NCT06471621 is sponsored by Insel Gruppe AG, University Hospital Bern. The principal investigator is Uyen Huynh-Do, Prof. MD at University Hospital Bern (Inselspital). The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.